期刊文献+

部分血浆凝血因子活性测定在急性冠脉综合征中的应用价值 被引量:1

Implications of partial plasma coagulation factor activity in acute coronary syndrome
下载PDF
导出
摘要 目的观察急性冠脉综合征(ACS)患者部分凝血因子活性水平,探讨其在ACS发病中的意义。方法测定100例急性心肌梗死(AMI)和69例不稳定性心绞痛(UAP)患者急性期凝血因子Ⅴ、Ⅶ、Ⅷ、Ⅹ、Ⅺ活性(FⅤ:C、FⅦ:C、FⅧ:C、FⅩ:C、FⅪ:C),并与120例稳定性心绞痛(SAP)患者和80例健康对照组进行比较,分析这些因子活性水平与AMl和UAP急性期的关系。结果 AMI和UAP患者急性期FⅤ:C、FⅦ:C、FⅧ:C、FⅩ:C、FⅪ:C水平明显高于SAP组和健康对照组(P<0.05));SAP组和健康对照组比较差异无统计学意义(P>0.05)。结论 ACS患者急性期FⅤ:C、FⅦ:C、FⅧ:C、FⅩ:C、FⅪ:C水平明显升高,存在高凝状态。 Objective To investigate the activity of partial plasma coagulation factor activity and its clinical Significance in occurrence of acute coronary syndrome(ACS). Methods The activities of coagulation factors(FⅤ:C, FⅦ :C, FⅧ :C, FⅩ:C and FⅪ :C) were measured in 100 patients with acute myocardial infarction(AMI group) and 69 patients with unstable angina pectoris in acute stage(UAP group), the results were compared with those of 120 cases of stable angina pectoris(SAP group) and 80 healthy controls(healthy control group). The relationship was analyzed between activities of coagulation factors and AMI as well as acute stage UAP. Results The patients with acute myocardial infarction and unstable angina pectoris in acute phase had significantly higher plasma FⅤ :C, FⅦ :C, FⅧ : C, FⅩ:C and FⅪ :C compared with those of healthy and SAP subjects(P〈0.05); there were no significant differences of the above activities between SAP group and healthy control group(P〉0.05). Conclusion Significantly higher activation of FⅤ :C, FⅦ :C, FⅧ : C, FⅩ:C and FⅪ :C and a hypercoagutabale state exist in acute coronary syndrome(ACS) patients in acute stage.
作者 蔡莉莉
出处 《国际检验医学杂志》 CAS 2009年第3期212-213,216,共3页 International Journal of Laboratory Medicine
关键词 冠状动脉硬化 血液凝固因子 临床实验室技术 Coronary arteriosclerosis Blood coagulation factors Clinical laboratory techtuques
  • 相关文献

参考文献5

  • 1Ardissino D,Merlini PA, Gamba G, et al. Thrombin activity and early outcome in unstable angina peetoris [J]. Circulation, 1996, 93(9) : 1634-1639.
  • 2Zaman AG, Helft G, Worthley SG, et al. The role of plaque rupture and thrombosis in coronary artery disease [J]. Atherosclerosis, 2000,149(2):251-266.
  • 3杨林花,董春霞,魏文宁,杨焰,杨锐,王凤芝.凝血因子Ⅴ和凝血因子Ⅷ活性的变化与冠心病的关系[J].临床血液学杂志,2004,17(2):70-72. 被引量:7
  • 4Murohara T, Buerke M, Lefer AM. Polymorphonuclear leukocyteinduced vasocontraction and endothelial dysfunction: role of selectins [J]. Arterioscler Thromb, 1994,14(9):1509-1519.
  • 5Klinkhardt U, Graff J, Harder S. Ciopidogrei, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human cx vivo in vitro model [J]. Clin Pharmaeol Ther,2002,71 (3) :176-185.

二级参考文献10

  • 1国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(2):75-75.
  • 2魏文宁 郭秀枝.血栓性疾病的诊断和治疗[M].北京:人民卫生出版社,2000.50-65.
  • 3Meade T W, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet,1986, 2: 533-537.
  • 4Thompson S G, Kienast J, Pyke S D M, et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European concerted action on thrombosis and disabilities angina pectoris study group. NEnglJ Med, 1995, 332: 635-641.
  • 5Scarabin P Y, Aillaud M F, Amouyel P, et al. Associations of fibrinogen, factor Ⅷ and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction-the PRIME Study.Prospective epidemiological study of myocardial infarction. Thromb Haemost, 1998, 80: 749-756.
  • 6Rosendaal F R, Siscovick D S, Schwartz S M, et al.Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood, 1997, 89: 2817-2821.
  • 7Rees D C, Cox M, Clegg J B . World distribution of factor V leiden. Lancet, 1995, 346: 1133-1134.
  • 8Kawasaki T, Kaida T, Arnout J, et al. A new animal model of thrombophilia confirms that high plasma factor Ⅷ levels are thrombogenic. Thromb Haemost, 1999,81: 306-311.
  • 9Folsom A R, Wu K K, Rosamond W D, et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Circulation, 1997,96: 1102-1108.
  • 10乐玮,于金德,陆林,陶蓉,尤蓓,龚兰生.凝血因子Ⅴ多态性、活性与冠心病关系的研究[J].中华心血管病杂志,2000,28(1):22-26. 被引量:5

共引文献6

同被引文献4

  • 1WHITE H, ZOLLINGER C, JONES M, et al. Can Thromboelastogra- phy performed on kaolin-activated citrated samples from critically ill patients provide stable and consistent parameters [ J ]. Int J Lab He- matol,2010,32 (2) :167-173.
  • 2ABDULLAH WZ, MOUFAK SK, YUSOF Z, et al. Shortened activated partial thromboplastin time, a hemostatie marker for hypercoagulabie state during acute coronary event [ J 1. Transl Res, 2010, 155 ( 6 ) : 315-319.
  • 3LEVEI, RAMCHANDANI M, GARG R, et al. Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular sur- gery[ J]. J Thromb Thron:bolysis ,2007,24( 1 ) : 15-21.
  • 4韩旭东,黄晓英,殷国平,王芳,陈家华,李名,王美兰,章幼奕.血栓弹力图与传统凝血试验评价肝病凝血功能的相关性研究[J].交通医学,2010,24(2):162-164. 被引量:14

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部